국소 흉터 치료 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 흉터 유형별, 유통 채널별, 지역별, 부문별 예측(2025-2030년)

Topical Scar Treatment Market Growth & Trends:

The global topical scar treatment market size is estimated to reach USD 3.31 billion by 2030, registering to grow at a CAGR of 11.9% from 2025 to 2030 according to a new report by Grand View Research, Inc. The increasing prevalence of burn injuries, skin-related disorders, and trauma are major factors likely to contribute to market growth. Topical products are a variety of substances, compounds, or mixtures that are designed for application on the skin, hair, or nails, with a purpose to exert their effects specifically on the applied area. They are frequently incorporated into routines for personal care, including skincare and haircare.

Moreover, the market is likely to be driven by the growing acceptance of ambulatory surgery centers and introduction of portable or mobile devices for scar treatment in both developed and developing regions. The market has seen significant technological advancements, including the introduction of laser therapies such as the Q-switched laser-based device, MedLite C6, which is specifically designed for treating acne. These laser instruments assist in the breakdown of scar tissue, thereby simplifying scar treatment procedures.

A model was established by examining the occurrence of scars across different regions and countries. It was observed that most patients preferred topical treatments for managing their scars. The usage rates of creams, gels, silicon sheets, and other products were subsequently analyzed. Furthermore, factors such as the average pricing of products, their usability, and the duration of treatment were considered to estimate the market size and allocate the segment division for each type of product.

Topical Scar Treatment Market Report Highlights:

• By product, creams dominated the market with a revenue share of 36.09% in 2024. Topical creams have specific vitamins and other skincare ingredients that help reduce a scar's appearance and is expected to positively impact the market growth.
• By scar type, atrophic scars dominated the market and accounted for 37.15%. This type of scar looks like a pit and is typically caused by staphylococcus infections, acne, chickenpox, and surgery. As the demand for aesthetic appeal grows, the need for topical products to treat atrophic scars also increases.
• Retail pharmacies dominated the market with a revenue share of 40.30% in 2024, driven by government support and industry consolidation, which enhances efficiency and cost-effectiveness.
• In 2024, Asia-Pacific dominated the market with a revenue share of 44.7%. The region's growing healthcare infrastructure, high aesthetic consciousness among people, rapid adoption of advanced products, and a growing aging population contributes to the market's dominance

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Scar Type
  • 1.2.3. Distribution Channel
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Scar type outlook
  • 2.2.3. Distribution channel outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Topical Scar Treatment Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing demand for aesthetics
    • 3.2.1.2. Growing number of road accidents and burn cases
    • 3.2.1.3. Growing technological advancements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Limited effectiveness for severe scars
    • 3.2.2.2. Consumer skepticism and slow adoption
  • 3.2.3. Market restraint analysis
    • 3.2.3.1. Growing awareness of skincare and personal appearance
    • 3.2.3.2. Growing popularity of e-commerce
• 3.3. Topical Scar Treatment Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Environmental landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Global Topical Scar Treatment Market: Product Estimates & Trend Analysis

• 4.1. Topical Scar Treatment Market: Product Dashboard
• 4.2. Topical Scar Treatment Market: Product Movement Analysis
• 4.3. Topical Scar Treatment Market Size & Forecasts and Trend Analyses, 2018 to 2030
• 4.4. Creams
  • 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.5. Gels
  • 4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.6. Silicon Sheets
  • 4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Global Topical Scar Treatment Market: Scar Type Estimates & Trend Analysis

• 5.1. Topical Scar Treatment Market: Scar Type Dashboard
• 5.2. Topical Scar Treatment Market: Scar Type Movement Analysis
• 5.3. Topical Scar Treatment Market Size & Forecasts and Trend Analyses, 2018 to 2030
• 5.4. Atrophic Scars
  • 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. Hypertrophic and Keloid Scars
  • 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.6. Contracture Scars
  • 5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.7. Stretch Marks
  • 5.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Global Topical Scar Treatment Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Topical Scar Treatment Market: Distribution Channel Dashboard
• 6.2. Topical Scar Treatment Market: Distribution Channel Movement Analysis
• 6.3. Topical Scar Treatment Market Size & Forecasts and Trend Analyses, 2018 to 2030
• 6.4. Hospital Pharmacies
  • 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Retail Pharmacies
  • 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6. Online
  • 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.7. Hypermarkets/ Supermarkets
  • 6.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Regional Estimates & Trend Analysis by Product, Scar Type, Distribution Channel

• 7.1. Global Topical Scar Treatment Market: Regional Dashboard
• 7.2. Global Topical Scar Treatment Market: Regional Movement Analysis
• 7.3. Global Topical Scar Treatment Market Size & Forecasts and Trend Analyses by Product, Scar Type, Distribution Channel, 2018 to 2030
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Mexico
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Germany
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Spain
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Denmark
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework/ reimbursement structure
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Norway
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Regulatory framework/ reimbursement structure
    • 7.5.8.3. Competitive scenario
    • 7.5.8.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. China
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. India
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Japan
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. South Korea
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Argentina
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework/ reimbursement structure
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework/ reimbursement structure
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework/ reimbursement structure
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework/ reimbursement structure
    • 7.8.4.3. Competitive scenario
    • 7.8.4.4. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2024
  • 8.3.4. Smith & Nephew
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Merz North America, Inc.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. LUMENIS
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Enaltus LLC
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Sonoma Pharmaceuticals, Inc.
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Molnlycke Health Care
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Cynosure, Inc.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. CCA Industries, Inc.
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Scar Heal Inc.
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. NewMedical Technology
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. Suneva Medical Inc.
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives
  • 8.3.15. Pacific World Corporation
    • 8.3.15.1. Company overview
    • 8.3.15.2. Financial performance
    • 8.3.15.3. Product benchmarking
    • 8.3.15.4. Strategic initiatives
  • 8.3.16. Perrigo Company plc
    • 8.3.16.1. Company overview
    • 8.3.16.2. Financial performance
    • 8.3.16.3. Product benchmarking
    • 8.3.16.4. Strategic initiatives